IL6 and acute myeloid leukemia: Additionally, 9 of 20 patients with AML showed poor prognosis and died from cancer within 3 months of the blood collection, and they had higher plasma IL-6 levels and N-Shh expression on testing than the AML patients who were alive at that point (Table 2).